October 12, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for July 24, 2007 Subscribe to this News Feed  
 

Galea Life Sciences Begins Trading

Download this press release as an Adobe PDF document.

Galea Lifes Sciences Inc. today announced that it has begun trading under its new name and symbol. Galea was formerly known as Value Holdings Inc.

Galea Lifes Sciences Inc. (OTC: GLSN) today announced that it has begun trading under its new name and symbol. Galea was formerly known as Value Holdings Inc.

The Company changed its name to better reflect its new direction in anticipation of the completion of its acquisition of Innovative Technology Acquisition Corp., and that company’s Nutraplete dietary supplement. Nutraplete is designed to provide nutritional support for people with HIV/AIDS.

Concurrent with the name change the Company also executed a 25-1 reverse stock split.

About Innovative Technology Acquisition Corp.

Innovative Technology Acquisition Corp. is the developer of functional foods and dietary supplements. Innovative acquired BioSource Therapeutics, Inc. an entrepreneurial life science company, in 2002. BST specializes in the formulation, manufacturing, marketing and distribution of innovative dietary supplements that benefit people undergoing medical treatments and therapies. www.nutraplete.com

About Galea Life Sciences

Galea Lifes Sciences, Inc. (Other OTC:GLSN) is currently a non reporting, over the counter (``OTC'') publicly traded company. The Company's corporate goal is to build well-run independent subsidiaries that have solid market niches with compounded growth rates in terms of revenues and earnings.

Certain statements in this release constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast," "project," "intend," "expect" "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (finance or operating) or achievements to differ from future results, performance (financing and operating) or achievements expressed or implied by such forward-looking statements.

Statements herein express management's beliefs and expectations regarding future performance and are forward-looking and involve risks and uncertainties, including, but not limited to, the ability to negotiate outstanding prior debts of acquired companies; properly identify acquisition partners; adequately perform due diligence; manage and integrate acquired businesses; react to quarterly fluctuations in results; raise working capital and secure other financing; respond to competition and rapidly changing technology; deal with market and stock price fluctuations; and other risks.

Alison Choen
877-576-8872
info @ nutraplete.com

###

Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1Db3VwLUluc2UtU3F1YS1UaGlyLVplcm8=


See the original story at: http://www.prweb.com/releases/2007/07/prweb542246.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Alison Choen
Galea Life Sciences Inc.
877-576-8872
Email us Here
877-576-8872

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright